Financials
- Market Capitalization 12.52 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
22.89
売上高対価格比率
5.77
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 778 | SMMT Summit Therapeutics Inc. - Common Stock | 16.94 USD | +16.03% | +18.21% | +28.33% | -14.70% | 13.51 B USD | ||
| 793 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.72 USD | -0.59% | -0.24% | +10.35% | +28.35% | 12.56 B USD | ||
| 822 | CORT Corcept Therapeutics Incorporated - Common Stock | 114.22 USD | +3.43% | -3.42% | +1.08% | +55.68% | 12.35 B USD | ||
| 825 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 85.30 USD | -0.08% | -3.62% | -2.20% | +118.16% | 12.05 B USD |